Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
| Autor: | Sax, Paul E, Pozniak, Anton, Montes, M Luisa, Koenig, Ellen, DeJesus, Edwin, Stellbrink, Hans-Jürgen, Antinori, Andrea, Workowski, Kimberly, Slim, Jihad, Reynes, Jacques, Garner, Will, Custodio, Joseph, White, Kirsten, SenGupta, Devi, Cheng, Andrew, Quirk, Erin |
|---|---|
| Zdroj: | In The Lancet 4-10 November 2017 390(10107):2073-2082 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|